搜索优化
English
全部
搜索
Copilot
图片
视频
地图
资讯
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
同花顺股票频道
17 天
贝达药业:RGB-5088胰岛细胞注射液处于临床研究阶段
公司回答表示:公司战略合作伙伴杭州瑞普晨创科技有限公司自主研发的RGB-5088胰岛细胞注射液的临床试验申请已于2024年12月获国家药品监督管理局批准,目前处于临床研究阶段。有关RGB-5088胰岛细胞注射液的临床研究进展情况,您可以关注瑞普晨创官方网站的 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
DC cherry blossoms 2025
Dogs kill mother, charged
SCOTUS declines challenge
Glaser on political jokes
Officials texted war plans?
Trump admin accuses Khalil
NewJeans announces hiatus
Incendiary devices found
Named US attorney for NJ
Recalled over bacteria risk
25% Venezuela oil, gas tariff
$21 billion US investment
German startup delays launch
Feds open safety probe
Wildfires in western Japan
US targets Houthi rebels
Hikes airport lounge fees
Weighs LA electoral map
Weiss pleads not guilty
Homestead Cup Series win
Asks to halt order to rehire
Check in at police station
Turkey detains journalists
Monarez to lead CDC?
Confirmed as Navy secretary
Judge blocks A&M drag ban
Wildfires scorch Carolinas
Nadine Menendez trial
USPS chief DeJoy resigns
Carried off floor w/ injury
Sac State to hire Mike Bibby
Deal to share data with ICE
Former UFC champion sentenced
反馈